Cargando…
Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
Autores principales: | Pardo-Cabello, Alfredo Jose, Manzano-Gamero, Victoria, Belda-Rustarazo, Susana, Giner-Escobar, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847534/ https://www.ncbi.nlm.nih.gov/pubmed/33517559 http://dx.doi.org/10.1007/s11739-021-02645-8 |
Ejemplares similares
-
Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply
por: Crescioli, Giada, et al.
Publicado: (2021) -
Differences in reporting of adverse drug reactions due to COVID-19 vaccines depending on the reporter
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2023) -
Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2023) -
Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions
por: Crescioli, Giada, et al.
Publicado: (2020) -
Patient Perspective, Complexities, and Challenges in Managed Care
por: Jan, Saira
Publicado: (2010)